Cargando…

Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis

BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiding, Wu, Guiling, Liu, Jinqiang, Zhang, Yujie, Yang, Wanli, Wang, Xiaoqian, Duan, Lili, Niu, Liaoran, Chen, Junfeng, Zhou, Wei, Han, Weili, Wang, Jing, Zhong, Helun, Ji, Gang, Fan, Daiming, Hong, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251690/
https://www.ncbi.nlm.nih.gov/pubmed/37291493
http://dx.doi.org/10.1186/s12885-023-10805-6
_version_ 1785055996881666048
author Li, Yiding
Wu, Guiling
Liu, Jinqiang
Zhang, Yujie
Yang, Wanli
Wang, Xiaoqian
Duan, Lili
Niu, Liaoran
Chen, Junfeng
Zhou, Wei
Han, Weili
Wang, Jing
Zhong, Helun
Ji, Gang
Fan, Daiming
Hong, Liu
author_facet Li, Yiding
Wu, Guiling
Liu, Jinqiang
Zhang, Yujie
Yang, Wanli
Wang, Xiaoqian
Duan, Lili
Niu, Liaoran
Chen, Junfeng
Zhou, Wei
Han, Weili
Wang, Jing
Zhong, Helun
Ji, Gang
Fan, Daiming
Hong, Liu
author_sort Li, Yiding
collection PubMed
description BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival (OS) of gastric cancer (GC). METHODS: Through a systematic review till March 7, 2022, we identified population-based studies that reported the prognostic effects of LODDS in patients with GC. We compare the predictive effectiveness of the LODDS staging system with that of the rN and pN classification systems for the OS of GC. RESULTS: Twelve studies comprising 20,312 patients were included in this systematic review and meta-analysis. The results showed that LODDS1, LODDS2, LODDS3, and LODDS4 in GC patients were correlated with poor OS compared with LODDS0 (LODDS1 vs. LODDS0: HR = 1.62, 95% CI (1.42, 1.85); LODDS2 vs. LODDS0: HR = 2.47, 95% CI (2.02, 3.03); LODDS3 vs. LODDS0: HR = 3.15, 95% CI (2.50, 3.97); LODDS4 vs. LODDS0: HR = 4.55, 95% CI (3.29, 6.29)). Additionally, significant differences in survival were observed among patients with different LODDS classifications (all P-values were < 0.001) with the same rN and pN classifications. Meanwhile, for patients with different pN or rN classifications with the same LODDS classification, prognosis was highly similar. CONCLUSION: The findings show that LODDS is correlated with the prognosis of GC patients and is superior to the pN and rN classifications for prognostic assessment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10805-6.
format Online
Article
Text
id pubmed-10251690
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102516902023-06-10 Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis Li, Yiding Wu, Guiling Liu, Jinqiang Zhang, Yujie Yang, Wanli Wang, Xiaoqian Duan, Lili Niu, Liaoran Chen, Junfeng Zhou, Wei Han, Weili Wang, Jing Zhong, Helun Ji, Gang Fan, Daiming Hong, Liu BMC Cancer Research BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival (OS) of gastric cancer (GC). METHODS: Through a systematic review till March 7, 2022, we identified population-based studies that reported the prognostic effects of LODDS in patients with GC. We compare the predictive effectiveness of the LODDS staging system with that of the rN and pN classification systems for the OS of GC. RESULTS: Twelve studies comprising 20,312 patients were included in this systematic review and meta-analysis. The results showed that LODDS1, LODDS2, LODDS3, and LODDS4 in GC patients were correlated with poor OS compared with LODDS0 (LODDS1 vs. LODDS0: HR = 1.62, 95% CI (1.42, 1.85); LODDS2 vs. LODDS0: HR = 2.47, 95% CI (2.02, 3.03); LODDS3 vs. LODDS0: HR = 3.15, 95% CI (2.50, 3.97); LODDS4 vs. LODDS0: HR = 4.55, 95% CI (3.29, 6.29)). Additionally, significant differences in survival were observed among patients with different LODDS classifications (all P-values were < 0.001) with the same rN and pN classifications. Meanwhile, for patients with different pN or rN classifications with the same LODDS classification, prognosis was highly similar. CONCLUSION: The findings show that LODDS is correlated with the prognosis of GC patients and is superior to the pN and rN classifications for prognostic assessment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10805-6. BioMed Central 2023-06-08 /pmc/articles/PMC10251690/ /pubmed/37291493 http://dx.doi.org/10.1186/s12885-023-10805-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Yiding
Wu, Guiling
Liu, Jinqiang
Zhang, Yujie
Yang, Wanli
Wang, Xiaoqian
Duan, Lili
Niu, Liaoran
Chen, Junfeng
Zhou, Wei
Han, Weili
Wang, Jing
Zhong, Helun
Ji, Gang
Fan, Daiming
Hong, Liu
Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title_full Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title_fullStr Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title_full_unstemmed Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title_short Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
title_sort log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251690/
https://www.ncbi.nlm.nih.gov/pubmed/37291493
http://dx.doi.org/10.1186/s12885-023-10805-6
work_keys_str_mv AT liyiding logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT wuguiling logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT liujinqiang logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT zhangyujie logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT yangwanli logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT wangxiaoqian logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT duanlili logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT niuliaoran logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT chenjunfeng logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT zhouwei logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT hanweili logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT wangjing logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT zhonghelun logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT jigang logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT fandaiming logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis
AT hongliu logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis